[Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats]
- PMID: 15301110
[Neuroprotective effect of erigeron breviscapus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats]
Abstract
Purpose: To investigate if Erigeron Breviscapus (vant) Hand-Mazz (EBHM) has a neuroprotective effect against NMDA-induced neuron death in retinal ganglion cell layer (RGCL).
Methods: Sixty healthy SD rats were randomly divided into four groups. 6 animals were in normal control group (group A). The others were divided as group B (EBHM group), group C (normal saline+NMDA group), group D (EBHM+NMDA group). Each group has 18 rats. 10 nmol NMDA was chosen for intravitreal injection to cause partial damage of the neurons in RGCL in the right eyes of Groups C and D. Same volume PBS was intravitreal injected in the left eyes as self-control. Groups B and D were pre-treated intraperitoneally with 6% EBHM solution at a dose of 15 mg x 100 g(-1) x d(-1) seven days before and after NMDA treatment. Group C were administrated intraperitoneally with 0.9% normal saline at the same time of EBHM injection. Rats were sacrificed in 4, 7, 14 days after NMDA treatment. Flat preparation of whole retinas were stained with 0.5% cresyl violet and neuron counting in RGCL from both eyes. Each subgroup has 6 rats.
Results: There was no significant difference between the right eye and the left eye of neuron counting from RGCL in normal control group (group A) (P=0.200). There was no significant difference between normal control group and EBHM group either in the right eyes or in the left eye in 4 days, 7 days and 14 days respectively after intravitreal injection of 10 nmol NMDA in group C and group D. (P=0.636, P=0.193). Neuron counting from RGCL of group C and group D were significant decreased in the NMDA-treated eyes in 4 days, 7 days and 14 days after intravitreal injection (P < 0.001). There ws no significant difference between self-control eyes and normal control group (P > 0.05). Neuron counting was significantly higher in the EBHM+NMDA group than normal saline+NMDA group at 14 days after intraviteal injection (P=0.044). However,it is obvious that the difference was still significant between normal control group and EBHM+NMDA group (P < 0.05).
Conclusion: EBHM has no effect on neuron counting of RGCL when administered alone in normal rats. It is suggested that EBHM has partial protective effect on NMDA-induced neuron loss in RGCL in the rat.
Similar articles
-
[The neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury].Zhonghua Yan Ke Za Zhi. 2003 Aug;39(8):481-4. Zhonghua Yan Ke Za Zhi. 2003. PMID: 14642169 Chinese.
-
[The affect of Erigeron Breviscapus (Vant.) Hand-Mazz on axoplasmic transport of optic nerve in rats with experimentally elevated intraocular pressure].Zhonghua Yan Ke Za Zhi. 2000 Jul;36(4):289-91, 18. Zhonghua Yan Ke Za Zhi. 2000. PMID: 11853617 Chinese.
-
[Morphological changes of retina after N-methyl-D-aspartate induced damage in rats].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Jun;29(3):287-91. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 16136962 Chinese.
-
Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer's Disease.Front Pharmacol. 2022 Apr 26;13:877872. doi: 10.3389/fphar.2022.877872. eCollection 2022. Front Pharmacol. 2022. PMID: 35559239 Free PMC article. Review.
-
Advances in Anti-Diabetic Cognitive Dysfunction Effect of Erigeron Breviscapus (Vaniot) Hand-Mazz.Pharmaceuticals (Basel). 2022 Dec 29;16(1):50. doi: 10.3390/ph16010050. Pharmaceuticals (Basel). 2022. PMID: 36678547 Free PMC article. Review.
Cited by
-
Caffeic acid ester fraction from Erigeron breviscapus inhibits microglial activation and provides neuroprotection.Chin J Integr Med. 2012 Jun;18(6):437-44. doi: 10.1007/s11655-012-1114-y. Epub 2012 Jul 22. Chin J Integr Med. 2012. PMID: 22821656
-
Rational Basis for Nutraceuticals in the Treatment of Glaucoma.Curr Neuropharmacol. 2018;16(7):1004-1017. doi: 10.2174/1570159X15666171109124520. Curr Neuropharmacol. 2018. PMID: 29119928 Free PMC article. Review.
-
The Involvement of β-Catenin/COX-2/VEGF Axis in NMDA-Caused Retinopathy.J Ophthalmol. 2017;2017:9760501. doi: 10.1155/2017/9760501. Epub 2017 Oct 12. J Ophthalmol. 2017. PMID: 29158916 Free PMC article.
-
Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells.Int J Ophthalmol. 2015 Dec 18;8(6):1101-6. doi: 10.3980/j.issn.2222-3959.2015.06.04. eCollection 2015. Int J Ophthalmol. 2015. PMID: 26682155 Free PMC article.
-
Protective effects of Erigeron breviscapus Hand.- Mazz. (EBHM) extract in retinal neurodegeneration models.Mol Vis. 2018 Apr 25;24:315-325. eCollection 2018. Mol Vis. 2018. PMID: 29769797 Free PMC article.